{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:25:09Z","timestamp":1793237109076,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Science and Technology Bureau","doi-asserted-by":"crossref","award":["ZY2022024"],"award-info":[{"award-number":["ZY2022024"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82401829"],"award-info":[{"award-number":["82401829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2024J313"],"award-info":[{"award-number":["2024J313"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01389-6","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:23:28Z","timestamp":1778919808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolic stress exacerbates Parkinson\u2019s disease pathology through mitochondrial dysfunction and ferroptosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Yanyan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongpeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(25)00287-X","volume":"24","author":"ER Dorsey","year":"2025","unstructured":"Dorsey, E. R. et al. Environmental toxicants and Parkinson\u2019s disease: recent evidence, risks, and prevention opportunities. Lancet Neurol. 24, 976\u2013986 (2025).","journal-title":"Lancet Neurol."},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya, H. et al. Widespread distribution of alpha-synuclein oligomers in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol. 149, 42 (2025).","journal-title":"Acta Neuropathol."},{"key":"1389_CR3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1126\/science.adp3645","volume":"387","author":"KM Wu","year":"2025","unstructured":"Wu, K. M. et al. Neuronal FAM171A2 mediates alpha-synuclein fibril uptake and drives Parkinson\u2019s disease. Science 387, 892\u2013900 (2025).","journal-title":"Science"},{"key":"1389_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41531-025-00913-4","volume":"11","author":"F Cao","year":"2025","unstructured":"Cao, F. et al. Speech and language biomarkers for Parkinson\u2019s disease prediction, early diagnosis and progression. NPJ Parkinsons Dis. 11, 57 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","volume":"9","author":"Y Qu","year":"2023","unstructured":"Qu, Y. et al. A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 18 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"e095610","DOI":"10.1136\/bmjopen-2024-095610","volume":"15","author":"M Li","year":"2025","unstructured":"Li, M. et al. Global burden of Parkinson\u2019s disease from 1990 to 2021: a population-based study. BMJ Open 15, e095610 (2025).","journal-title":"BMJ Open"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"Collaborators, G.B.D.C.o.D.","year":"2024","unstructured":"Collaborators, G.B.D.C.o.D. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132 (2024).","journal-title":"Lancet"},{"key":"1389_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15018-x","volume":"23","author":"S Safiri","year":"2023","unstructured":"Safiri, S. et al. The burden of Parkinson\u2019s disease in the Middle East and North Africa region, 1990\u20132019: results from the global burden of disease study 2019. BMC Public Health 23, 107 (2023).","journal-title":"BMC Public Health"},{"key":"1389_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/cge.14019","volume":"100","author":"A Mahmood","year":"2021","unstructured":"Mahmood, A. et al. Recalling the pathology of Parkinson\u2019s disease; lacking exact figure of prevalence and genetic evidence in Asia with an alarming outcome: A time to step-up. Clin. Genet. 100, 659\u2013677 (2021).","journal-title":"Clin. Genet."},{"key":"1389_CR10","doi-asserted-by":"crossref","unstructured":"Chand, P. et al. Advances in Gene Therapy for Neurologic Disorders: An Overview. BIOI. 6, 1-17 (2025).","DOI":"10.15212\/bioi-2024-0060"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"101727","DOI":"10.1016\/j.arr.2022.101727","volume":"81","author":"M Faizan","year":"2022","unstructured":"Faizan, M., Sarkar, A. & Singh, M. P. Type 2 diabetes mellitus augments Parkinson\u2019s disease risk or the other way around: Facts, challenges and future possibilities. Ageing Res Rev. 81, 101727 (2022).","journal-title":"Ageing Res Rev."},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","volume":"36","author":"H Chohan","year":"2021","unstructured":"Chohan, H. et al. Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression. Mov. Disord. 36, 1420\u20131429 (2021).","journal-title":"Mov. Disord."},{"key":"1389_CR13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/mds.29122","volume":"37","author":"D Athauda","year":"2022","unstructured":"Athauda, D. et al. The impact of Type 2 diabetes in Parkinson\u2019s ssease. Mov. Disord. 37, 1612\u20131623 (2022).","journal-title":"Mov. Disord."},{"key":"1389_CR14","doi-asserted-by":"publisher","first-page":"11847","DOI":"10.3390\/ijms222111847","volume":"22","author":"A Jurcau","year":"2021","unstructured":"Jurcau, A. Insights into the pathogenesis of neurodegenerative diseases: Focus on mitochondrial dysfunction and oxidative stress. Int. J. Mol. Sci. 22, 11847 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","volume":"74","author":"AH Bhat","year":"2015","unstructured":"Bhat, A. H. et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed. Pharmacother. 74, 101\u2013110 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0962280210394459","volume":"21","author":"TM Palmer","year":"2012","unstructured":"Palmer, T. M. et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat. Methods Med. Res. 21, 223\u2013242 (2012).","journal-title":"Stat. Methods Med. Res."},{"key":"1389_CR17","unstructured":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17: p. 939\u2013953 (2018)."},{"key":"1389_CR18","doi-asserted-by":"crossref","unstructured":"Chu, L. X. et al. Convergence of Epidemiology and Modifiable Causal Risk Factors in Inflammatory Bowel Disease and Alzheimer\u2019s Disease. BIOI. 7, 1-17 (2026).","DOI":"10.15212\/bioi-2026-0023"},{"key":"1389_CR19","doi-asserted-by":"publisher","first-page":"882241","DOI":"10.3389\/fendo.2022.882241","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen, Y. et al. The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990\u20132019. Front. Endocrinol. 13, 882241 (2022).","journal-title":"Front. Endocrinol."},{"key":"1389_CR20","doi-asserted-by":"publisher","first-page":"1554442","DOI":"10.3389\/fmed.2025.1554442","volume":"12","author":"W Cao","year":"2025","unstructured":"Cao, W. et al. Global, regional, and National Temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990\u20132021: an age-period-cohort analysis based on the global burden of disease study 2021. Front. Med. 12, 1554442 (2025).","journal-title":"Front. Med."},{"key":"1389_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41531-024-00779-y","volume":"10","author":"GM Pereira","year":"2024","unstructured":"Pereira, G. M. et al. A systematic review and meta-analysis of the prevalence of Parkinson\u2019s disease in lower to upper-middle-income countries. npj Parkinson\u2019s. Dis. 10, 181 (2024).","journal-title":"npj Parkinson\u2019s. Dis."},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"1370282","DOI":"10.3389\/fpubh.2024.1370282","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Distinct time trends in colorectal cancer incidence in countries with SDI levels from 1990 to 2019: an age\u2013period\u2013cohort analysis for the Global Burden of Disease 2019 study. Front. Public Health 12, 1370282 (2024).","journal-title":"Front. Public Health"},{"key":"1389_CR23","doi-asserted-by":"publisher","first-page":"104319","DOI":"10.1016\/j.jrp.2022.104319","volume":"102","author":"SJ McCann","year":"2023","unstructured":"McCann, S. J. Neuroticism, urbanization, and the state prevalence of Parkinson\u2019s disease in the USA. J. Res. Personal. 102, 104319 (2023).","journal-title":"J. Res. Personal."},{"key":"1389_CR24","unstructured":"Su, D., et al. Projections for Prevalence of Parkinson\u2019s Disease and its Driving Factors in 204 Countries and Territories to 2050: A Systematic Analysis of the Global Burden of Disease Study 2019. Available at SSRN 4664553."},{"key":"1389_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1478-4491-4-12","volume":"4","author":"G Dussault","year":"2006","unstructured":"Dussault, G. & Franceschini, M. C. Not enough there, too many here: understanding geographical imbalances in the distribution of the health workforce. Hum. Resour. health 4, 12 (2006).","journal-title":"Hum. Resour. health"},{"key":"1389_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.parkreldis.2018.05.026","volume":"55","author":"A Marques","year":"2018","unstructured":"Marques, A. et al. Glucose dysregulation in Parkinson\u2019s disease: Too much glucose or not enough insulin?. Parkinson. Relat. Disord. 55, 122\u2013127 (2018).","journal-title":"Parkinson. Relat. Disord."},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"608736","DOI":"10.3389\/fnagi.2021.608736","volume":"13","author":"M Perticone","year":"2021","unstructured":"Perticone, M. et al. One hour-post-load plasma glucose\u2265 155 mg\/dl in healthy glucose normotolerant subjects is associated with subcortical brain MRI alterations and impaired cognition: a pilot study. Front. Aging Neurosci. 13, 608736 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1389_CR28","doi-asserted-by":"crossref","unstructured":"Kim, R. et al. Association of long-term glycemic variability with longitudinal motor and nonmotor progression in patients with Parkinson\u2019s disease: an 8-year follow-up. Age Ageing. 54, afaf220. (2025).","DOI":"10.1093\/ageing\/afaf220"},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.14802\/jmd.23264","volume":"17","author":"KE Choi","year":"2024","unstructured":"Choi, K. E. et al. Fasting plasma glucose levels and longitudinal motor and cognitive outcomes in Parkinson\u2019s disease patients. J. Mov. Disord. 17, 198\u2013207 (2024).","journal-title":"J. Mov. Disord."},{"key":"1389_CR30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/archneurol.2011.725","volume":"68","author":"D Weintraub","year":"2011","unstructured":"Weintraub, D. et al. Neurodegeneration across stages of cognitive decline in Parkinson's disease. Arch. Neurol. 68, 1562\u20131568 (2011).","journal-title":"Arch. Neurol."},{"key":"1389_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41392-024-02071-0","volume":"10","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases. Signal Transduct. Target Ther. 10, 31 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"1389_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13018-024-05293-8","volume":"20","author":"W Chen","year":"2025","unstructured":"Chen, W. et al. Validation and the role of PDK4 relevant to ferroptosis in degenerative lumbar disc disease. J. Orthop. Surg. Res. 20, 30 (2025).","journal-title":"J. Orthop. Surg. Res."},{"key":"1389_CR33","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.4103\/NRR.NRR-D-23-01265","volume":"20","author":"Z Lin","year":"2025","unstructured":"Lin, Z. et al. NOX4 exacerbates Parkinson\u2019s disease pathology by promoting neuronal ferroptosis and neuroinflammation. Neural Regen. Res. 20, 2038\u20132052 (2025).","journal-title":"Neural Regen. Res."},{"key":"1389_CR34","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/s41401-025-01576-w","volume":"46","author":"WL Wu","year":"2025","unstructured":"Wu, W. L. et al. Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update. Acta Pharm. Sin. 46, 3129\u20133142 (2025).","journal-title":"Acta Pharm. Sin."},{"key":"1389_CR35","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P. et al. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J. Am. Soc. Nephrol. 27, 3253\u20133265 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00415-025-13030-2","volume":"272","author":"L Xu","year":"2025","unstructured":"Xu, L., Wang, Z. & Li, Q. Global trends and projections of Parkinson\u2019s disease incidence: a 30-year analysis using GBD 2021 data. J. Neurol. 272, 286 (2025).","journal-title":"J. Neurol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01389-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:33:08Z","timestamp":1785882788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01389-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01389-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"183"}}